Androstanolone
Top View
- (12) Patent Application Publication (10) Pub. No.: US 2008/0044390 A1 Jin Et Al
- Gpi Drug Classification Report
- Transdermal Delivery System for Hormones and Steroids
- Novel Factors in the Pathogenesis of Psoriasis and Potential Drug Candidates Are Found with Systems Biology Approach
- Drug-Induced Hyperandrogenism 121 10 Drug-Induced Hyperandrogenism
- Treat Endocrinol 2005; 4 (5): 293-309 REVIEW ARTICLE 1175-6349/05/0005-0293/$34.95/0
- LPO' Enforcement in 2021
- Product# Description Qty Price Product# Description Qty Price
- Customs Tariff - Schedule Xxi - 1
- Androstanolone Pharmaceutical Form(S)/Strength: Gel for Local Application P-RMS: FR/H/PSUR/0018/001 Date of FAR: 16.07.2010 4.3 Contraindications
- Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
- Safety Data Sheet
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Articles Safety and Efficacy of Testosterone for Women
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- Testosterone and Androstanolone in Rat Plasma and Tissues
- ICD-10-CM TABLE of DRUGS and CHEMICALS